Norepinephrine Plasma Membrane Transport Proteins
"Norepinephrine Plasma Membrane Transport Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sodium chloride-dependent neurotransmitter symporters located primarily on the PLASMA MEMBRANE of noradrenergic neurons. They remove NOREPINEPHRINE from the EXTRACELLULAR SPACE by high affinity reuptake into PRESYNAPTIC TERMINALS. It regulates signal amplitude and duration at noradrenergic synapses and is the target of ADRENERGIC UPTAKE INHIBITORS.
MeSH Number(s)
D12.776.157.530.450.625.186
D12.776.157.530.562.374.500.750
D12.776.543.585.450.625.186
D12.776.543.585.562.374.500.750
Concept/Terms
Norepinephrine Plasma Membrane Transport Proteins- Norepinephrine Plasma Membrane Transport Proteins
- Norepinephrine Transporter Protein
- Transporter Protein, Norepinephrine
- Sodium-Dependent Noradrenaline Transporter
- Noradrenaline Transporter, Sodium-Dependent
- Sodium Dependent Noradrenaline Transporter
- Noradrenaline Plasma Membrane Transport Proteins
- Norepinephrine Plasma Membrane Transporters
- Norepinephrine Transporter
- Transporter, Norepinephrine
- Neurotransmitter Transporters, Noradrenaline-Specific
- Neurotransmitter Transporters, Noradrenaline Specific
- Noradrenaline-Specific Neurotransmitter Transporters
- Transporters, Noradrenaline-Specific Neurotransmitter
- Noradrenaline Transporter
- Transporter, Noradrenaline
- Norepinephrine Plasma Membrane Transporter Proteins
- NET Protein, Neuronal
- Neuronal NET Protein
Below are MeSH descriptors whose meaning is more general than "Norepinephrine Plasma Membrane Transport Proteins".
Below are MeSH descriptors whose meaning is more specific than "Norepinephrine Plasma Membrane Transport Proteins".
This graph shows the total number of publications written about "Norepinephrine Plasma Membrane Transport Proteins" by people in Harvard Catalyst Profiles by year, and whether "Norepinephrine Plasma Membrane Transport Proteins" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 4 | 4 |
| 2006 | 4 | 4 | 8 |
| 2007 | 1 | 0 | 1 |
| 2008 | 3 | 1 | 4 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 4 | 2 | 6 |
| 2013 | 0 | 3 | 3 |
| 2015 | 2 | 1 | 3 |
| 2017 | 1 | 1 | 2 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "Norepinephrine Plasma Membrane Transport Proteins" by people in Profiles.
-
Norepinephrine transporter and vesicular monoamine transporter 2 tumor expression as a predictor of response to 131 I-MIBG in patients with relapsed/refractory neuroblastoma. Pediatr Blood Cancer. 2024 Jan; 71(1):e30743.
-
Pharmacogenetics predictors of methylphenidate efficacy in childhood ADHD. Mol Psychiatry. 2018 09; 23(9):1929-1936.
-
Cocaine-like discriminative stimulus effects of "norepinephrine-preferring" monoamine releasers: time course and interaction studies in rhesus monkeys. Psychopharmacology (Berl). 2017 Dec; 234(23-24):3455-3465.
-
Vesicular monoamine transporter protein expression correlates with clinical features, tumor biology, and MIBG avidity in neuroblastoma: a report from the Children's Oncology Group. Eur J Nucl Med Mol Imaging. 2016 Mar; 43(3):474-481.
-
Association of the rs2242446 polymorphism in the norepinephrine transporter gene SLC6A2 and anxious arousal symptoms of posttraumatic stress disorder. J Clin Psychiatry. 2015 Apr; 76(4):e537-8.
-
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma. Clin Cancer Res. 2015 Jun 15; 21(12):2715-21.
-
Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 2014 Nov; 86:228-40.
-
No association of the norepinephrine transporter gene (SLC6A2) and cognitive and behavioural phenotypes of patients with autism spectrum disorder. Eur Arch Psychiatry Clin Neurosci. 2014 Sep; 264(6):507-15.
-
Influence of RGS2 on sertraline treatment for social anxiety disorder. Neuropsychopharmacology. 2014 May; 39(6):1340-6.
-
Cardiac sympathetic innervation and PGP9.5 expression by cardiomyocytes after myocardial infarction: effects of central MR blockade. Am J Physiol Heart Circ Physiol. 2013 Dec; 305(12):H1817-29.